Cardiosense, Inc., Completes $15.1 Million Series A Financing to Advance Artificial Intelligence Platform for Heart Disease

Summary by Ground News

Cardiosense, Inc. has raised $15.1 million in Series A funding. The capital will be used to support team expansion, accelerate product development, and fund an expansive heart failure study. The Company's first clinical application focuses on improving the management of congestive heart failure (CHF)

Published 2 months ago · Chicago, United States

News Articles

More Filters

All

Left

Center

Right

prnewswire.com

Cardiosense, Inc., Completes $15.1 Million Series A Financing to Advance Artificial Intelligence Platform for Heart Disease

/PRNewswire/ -- Cardiosense, Inc., a Chicago-based digital health company leveraging artificial intelligence and multi-sensor devices to enable early detection...

2 months ago·United States

Read Full Article

AiThority

Cardiosense, Inc., Completes $15.1 Million Series A Financing to Advance Artificial Intelligence Platform for Heart Disease

Cardiosense, Inc., a Chicago-based digital health company leveraging artificial intelligence and multi-sensor devices

2 months ago

Read Full Article

labpulse.com

Clinical-grade wearables developer Cardiosense raises $15.1M in Series A financing

The Chicago-based digital health company is leveraging artificial intelligence and multisensor devices to develop tools that enable the early detection of cardiovascular disease.

2 months ago

Read Full Article

Bias Distribution

100% of the sources are Center

C 100%

See less detail

Cardiosense, Inc., Completes $15.1 Million Series A Financing to Advance Artificial Intelligence Platform for Heart Disease

News Articles

Cardiosense, Inc., Completes $15.1 Million Series A Financing to Advance Artificial Intelligence Platform for Heart Disease

Cardiosense, Inc., Completes $15.1 Million Series A Financing to Advance Artificial Intelligence Platform for Heart Disease

Cardiosense, Inc., Completes $15.1 Million Series A Financing to Advance Artificial Intelligence Platform for Heart Disease

Cardiosense, Inc., Completes $15.1 Million Series A Financing to Advance Artificial Intelligence Platform for Heart Disease

Clinical-grade wearables developer Cardiosense raises $15.1M in Series A financing

Clinical-grade wearables developer Cardiosense raises $15.1M in Series A financing

Similar News Topics

Bias Distribution

Similar News Topics

Time & Location

News Coverage Details

Bias Distribution

Similar News Topics

Bias Distribution